Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent
Top Cited Papers
- 1 January 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 75 (1), 173-182
- https://doi.org/10.1161/HYPERTENSIONAHA.119.14071
Abstract
The Ang II (Angiotensin II)-Angiotensin-(1-7) axis of the Renin Angiotensin System encompasses 3 enzymes that form Angiotensin-(1-7) [Ang-(1-7)] directly from Ang II: ACE2 (angiotensin-converting enzyme 2), PRCP (prolylcarboxypeptidase), and POP (prolyloligopeptidase). We investigated their relative contribution to Ang-(1-7) formation in vivo and also ex vivo in serum, lungs, and kidneys using models of genetic ablation coupled with pharmacological inhibitors. In wild-type (WT) mice, infusion of Ang II resulted in a rapid increase of plasma Ang-(1-7). In ACE2(-/-)/PRCP-/- mice, Ang II infusion resulted in a similar increase in Ang-(1-7) as in WT (563 +/- 48 versus 537 +/- 70 fmol/mL, respectively), showing that the bulk of Ang-(1-7) formation in circulation is essentially independent of ACE2 and PRCP. By contrast, a POP inhibitor, Z-Pro-Prolinal reduced the rise in plasma Ang-(1-7) after infusing Ang II to control WT mice. In POP-/- mice, the increase in Ang-(1-7) was also blunted as compared with WT mice (309 +/- 46 and 472 +/- 28 fmol/mL, respectively P=0.01), and moreover, the rate of recovery from acute Ang II-induced hypertension was delayed (P=0.016). In ex vivo studies, POP inhibition with ZZP reduced Ang-(1-7) formation from Ang II markedly in serum and in lung lysates. By contrast, in kidney lysates, the absence of ACE2, but not POP, obliterated Ang-(1-7) formation from added Ang II. We conclude that POP is the main enzyme responsible for Ang II conversion to Ang-(1-7) in the circulation and in the lungs, whereas Ang-(1-7) formation in the kidney is mainly ACE2-dependent.Keywords
This publication has 64 references indexed in Scilit:
- Enzymatic processing of angiotensin peptides by human glomerular endothelial cellsAmerican Journal of Physiology-Renal Physiology, 2012
- Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory mannerBritish Journal of Pharmacology, 2010
- Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2Hypertension, 2010
- Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagenJournal of Neuroimmunology, 2009
- Prolylcarboxypeptidase regulates food intake by inactivating α-MSH in rodentsJCI Insight, 2009
- Circulating Activities of Angiotensin-Converting Enzyme, Its Homolog, Angiotensin-Converting Enzyme 2, and Neprilysin in a Family StudyHypertension, 2006
- S 17092-1, a Highly Potent, Specific and Cell Permeant Inhibitor of Human Proline EndopeptidaseBiochemical and Biophysical Research Communications, 1999
- A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: Angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11Life Sciences, 1993
- In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats.Hypertension, 1992
- Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II.Hypertension, 1982